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 Abstract 
 
Plethoric evidence reminds of the protective effects of exercise against a number of 
health risks, across all ages, in the general population. The benefits of exercise for 
individuals with type 2 diabetes are indisputable. An in-depth understanding of energy 
metabolism has reasonably entailed exercise as a cornerstone in the lifestyle of almost 
all subjects with type 1 diabetes. Nevertheless, individuals with type 1 diabetes often 
fail in accomplishing exercise guidelines and they are less active than their peer 
without diabetes. Two major obstacles are feared by people with type 1 diabetes who 
wish to exercise regularly: management of blood glucose control and hypoglycemia. 
Nowadays strategies, including glucose-monitoring technology and insulin pump 
therapy, have significantly contributed to the participation in regular physical activity, 
and even in competitive sports, for people with type 1 diabetes. Novel modalities of 
training, like different-intensity, interspersed exercise, are as well promising. 
The beneficial potential of exercise in type 1 diabetes is multi-faceted and it has to be 
fully exploited because it goes beyond the insulin-mimetic action, possibly through 
immunomodulation. 
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1. From type 2 to type 1 exercise-recommendations: over the guidelines 
In 1993, Kahn et al. first described the hyperbolic relationship between 
β-cell function and insulin sensitivity [1]. Physical exercise enables the 
achievement of better positions on the glucose-tolerance curve by ameliorating 
insulin sensitivity in any subject, either with type 2 (T2D) or type 1 diabetes 
(T1D). Traditionally, physical exercise is promoted in T2D where insulin 
action is deficient in the context of insulin resistance and/or inappropriate 
insulin secretion. However, even in T1D, in the dysregulation of immune 
system function, β-cell toxicity is mediated by a complex interplay between 
oxidative stress and inflammation, for which exercise could be protective. 
Recent studies have suggested that physical exercise may interfere with 
immune system function even at low intensity and duration.  
Although current guidelines are robust and straightforward in 
recommending doses of exercise (types, duration, intensity) for subjects with 
T2D, a complex and multifactorial strategy has been outlined for the exercise-
recommendations in T1D with a large and uncertain therapeutic range of 
efficacy (due to difficult glycemic control, and adherence). This advocates for a 
personalized, omni-comprehensive approach to fully exploit the exercise-
benefits in people with T1D. 
 
1.1 Immunomodulatory indications from animal and human models 
The nonobese diabetic (NOD) mouse has been studied as the elective 
model to mimic the diabetes progression in humans as it is characterized by 
progressive autoimmune destruction of pancreatic β-cells. We underwent 
NOD mice to a 12-week program of moderate-intensity treadmill training 
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to investigate immunological and inflammatory modifications during T1D 
progression [2]. We ascertained glucose-lowering effects induced by 
exercise in the late states of diabetes, whereas control untrained NOD mice 
revealed the presence of larger infiltrates at the end of the study. These 
results suggested that exercise may exert a positive immunomodulation of 
systemic functions to both T1D and inflammation. 
Within a unifying continuum of diabetes, we gathered a putative 
immunomodulatory effect of exercise in patients with T1D. According to 
our epidemiological screening, physical exercise would be able to prolong 
the “honeymoon”, i.e. the period of time, in early pathogenesis of T1D, 
characterized by reduced need for exogenous insulin. We have seen 
honeymoon to be definitively longer in active people, like athletes with 
T1D. Specifically, we found a putative inverse relationship between 
autoimmunity markers (GAD, IA) and exercise-derived energy expenditure 
[3, 4]. 
In other longitudinal studies (observational and intervention) we showed 
that exercise may positively modulate immune system function in β-cells 
transplanted recipients. Active subjects with T1D, following islet 
transplantation (IT), exhibited ameliorated scores of disease management, 
quality of life [5], metabolic control, body composition [6]. In addition, in 
IT subjects, physical exercise was capable to counteract diabetic symptoms 
and mitigated the side effects of immunosuppressive drugs and graft 
dysfunction [7, 8]. After IT, in fact, progressive insulin resistance might 
arise as a result of immunosuppression and chronic inflammation. 
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Literature reports several data supporting a complex interplay between 
immunological and metabolic scenarios. Fischer et al. demonstrated the 
involvement of interleukin-6 (IL-6) in the modulation of the immunological 
and metabolic responses to high-intensity exercise [9]. Ellingsgaard et al. 
documented positive effects of IL-6 on glucagon- [10] and insulin secretion 
through the action on glucagon-like peptide-1 (GLP-1) secretion, release, 
and subsequent β-cell signaling [11]. Da Silva Krause et al. confirmed that 
IL-6 promotes insulin secretion from clonal β-cells and pancreatic islets as 
this cytokine may exert GLP1-independent effects in the islet in vivo [12]. 
Suzuki et al. suggested IL-6 acts directly on pancreatic β-cells [13]. 
Altogether these IL-6 exercise-induced effects may restore the imbalance 
in the Th1/Th2 cytokines ratio observed in T1D, protecting from the 
autoimmune process directed to β-cells. We hypothesize that a direct 
exercise-intervention study would be capable to gain a greater effect on the 
immunological stand-point, as shown in previous studies. 
 
2. Exercise in T1D: the risk-benefit analysis 
Physical activity, sports and exercise should be encouraged in people with 
T1D for similar reasons it should be encouraged in people with T2D, or in the general 
population. Overall, regular exercise can decrease risk factors for cardiovascular 
diseases (CVD), it offers protection against all-cause mortality [4] and it may even 
improve quality of life in many individuals, under a variety of conditions [14]. 
Likewise for individuals with T2D, physical activity should be embodied in the 
management of T1D as it increases insulin sensitivity (both short and long term), 
lowers blood glucose levels, reduces body fat (and ameliorates body mass 
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composition [6]), improves cardiovascular function. However, due to the loss of the 
β-cell pancreatic mass and/or -function, subjects with T1D uniquely face a number of 
challenges in preparation for, during, and after each session of exercise. While the 
metabolic control is typically achievable in T2D as adaptive response to exercise, a 
successful management of blood glucose is instead uncertain in T1D. If insulin levels 
are excessive, hypoglycemia may arise during and after exercise. On the contrary, if 
insulin levels are deficient, exercise may lead to hyperglycemia or ketosis. 
Appropriate approaches, combining adjusted insulin therapy and diet, may 
accommodate daily exercise. However, an individualized risk-benefit analysis must 
be run when prescribing an exercise program for people with T1D. 
Strategies should be developed to minimize the risk of hypoglycemia – 
the most frequent event during/after exercise, given the derangements in fuel 
metabolism of individuals with T1D. Research in the area of exercise and diabetes has 
shown the importance of tight glucose control as a pillar in the management of T1D, 
especially under physical activity stimulation. Relevant precautions may include 
reduced doses of insulin in anticipation of exercise [15]; ingestion of readily 
absorbable carbohydrates [16]; adjustment of basal insulin infusion in pump therapy 
[17] (Figure 1). In fact, the insulin pump therapy, allowing a continuous subcutaneous 
insulin infusion (CSII), represents one of the most cost-effective approaches in 
different populations with T1D. Integrated monitoring systems, comprising CSII and 
continuous glucose monitoring (CGM), have been proved to be efficient in exploiting 
the beneficial effects of exercise within a comprehensive T1D-based educational 
approach. 
 
3. Abnormal endocrine responses to exercise in T1D 
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In healthy metabolism, glucose homeostasis is ensured during exercise 
through an array of neuroendocrine responses involving the growth hormone, cortisol, 
insulin, glucagon, and epinephrine. In other words, these responses modulate the 
balancing between glucose production and glucose utilization, during exercise, in 
order to maintain euglycemia (Figure 2). Unfortunately, these counter-regulatory 
responses may be abnormal or lost in T1D, and hypoglycemia arises as a frequent 
event among T1D-metabolic complications. In the early phase of the disease, usually 
before the onset of autonomic neuropathy, the sympathoadrenal responses are 
adequate to counteract hypoglycemia. However this defense can also be attenuated in 
later stages of T1D, and the consequent derangements, combined together, further 
increase the likelihood of hypoglycemia (hence, “hypoglycemia begets 
hypoglycemia”). Frequent hypoglycemia has been shown to reduce the glycemic 
threshold for activation of the counter-regulatory response needed to restore 
euglycemia during a subsequent hypoglycemic episode. As a result, some individuals 
develop hypoglycemia-associated autonomic failure (HAAF) and do not experience 
and respond to the potentially life-saving warning symptoms, therefore they are at 
increased risk of seizures, coma and death [18, 19]. Nevertheless, some recent studies 
found that in T1D, exercise and hypoglycemia may have mutual blunting effect to 
their counter-regulatory responses [20, 21].  
To summarize, blood glucose response to exercise is determined by a 
balance between hepatic glucose output and muscle glucose uptake; this balance is a 
function of diet, therapy, parameters related to exercise modality, and characteristics 
of the subjects. 
 
3.1 Exercise metabolism in health 
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During exercise, due to the increased metabolism, blood glucose is rapidly 
exhausted . However, there are physiological mechanisms helping to maintain 
euglycemic levels. Key metabolic pathways interact to regulate the rate of 
glucose metabolism and to direct cellular bioenergetics toward a defined 
homeostasis. These mechanisms include: 
1. Mobilization of glucose from liver glycogen stores; 
2. Mobilization of non-esterified fatty acid (NEFA) from adipose tissue (which 
spares blood glucose); 
3. Gluconeogenesis from the non-carbohydrate precursor such as amino acids, 
lactic acid, and glycerol; 
4. Blocking the entry of glucose into cells and forcing the cells to use NEFA as 
a fuel. 
 
3.2 Exercise dys-metabolism in T1D 
Glycolysis - Pyruvate and lactate concentration. Intense short-term exercise 
induces glycogen breakdown to provide the substrate for activating anaerobic 
glycolysis and to assure constant energy supply. However, the process results in 
accumulation of plasma pyruvate and lactate. Many studies have confirmed an 
increased concentration of serum lactate and pyruvate after exercise. 
Unfortunately, in T1D the pyruvate response is found to be blunted [22]. Given 
that insulin inhibits glycogen breakdown, the presence of increased insulin levels 
in T1D may result in a reduced glycogenolytic response [23]. 
Fat metabolism. During exercise, when the energy supply does not match the 
demand, a low plasma glucose level can occur. As a result, catecholamines are 
released to stimulate lipolysis. This process, which involves reduction of 
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triglycerides to free fatty acids, is catalyzed by lipase, and it is activated through 
the action of cortisol, epinephrine, norepinephrine, and growth hormone (GH). In 
response to exercise, healthy individuals show an increase in levels of free fatty 
acids and glycerol, as end-products of lipolysis [22, 24]. In T1D individuals, 
exercise-induced lipolysis is attenuated, again attributable to high insulin levels 
[23]. 
Protein metabolism. During exercise, when glucose is not available as the 
primary fuel, protein breakdown serves to provide an alternative source of energy. 
Studies indicate that high circulating insulin level in T1D may attenuate the 
process of protein breakdown. This is evidenced by lower levels of leucine, a 
product of protein breakdown [23].  
Insulin response. Serum insulin levels in T1D patients are found to be high after 
30 minutes of exercise. This increase in insulin could be one of the reasons for 
the diminished endocrine- and metabolic response to exercise in T1D [23]. 
Earlier, a study conducted to understand the exercise-induced lipolysis found 
increased levels of liposoluble vitamins in the blood stream, released from the 
subcutaneous fat tissue [24, 25]. This observation implies that the insulin stored 
in the subcutaneous tissue may be gradually released in response to exercise due 
to lipolysis. High levels of insulin may reach supra-physiological levels, leading 
to insulin resistance in T1D [26, 27]. In addition, studies have also found 
impaired glucose utilization and impaired insulin-induced NEFA suppression in 
T1D [28, 29]. Insulin resistance is also evidenced in hepatic and skeletal muscle 
tissue, despite good glycemic control in T1D [30]. A study conducted on T1D 
adolescents revealed impaired functional exercise capacity and decreased insulin 
sensitivity [31]. However, these individuals had paradoxically normal 
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intramyocellular lipid content (IMCL) which challenges the previous finding that 
IMCL accumulation a marker for insulin resistance in both T1D and T2D [32, 33]. 
 
3.3 Hypoglycemia and delayed glucose recovery 
T1D patients are at high risk of hypoglycemia following exercise; in addition, 
there is delayed glucose recovery from hypoglycemia attributable to blunted 
glucagon response, reduced adrenomedullary response, and diminished clearance 
of injected insulin. In healthy people, the pancreas secretes glucagon in response 
to hypoglycemia. Glucagon stimulates the breakdown of glycogen in the liver 
(hepatic glycogenolysis). As a result, the glycogen is converted to glucose, 
thereby normalizing plasma glucose levels. Many studies have proved the fact 
that plasma glucagon response to hypoglycemia is markedly attenuated in 
diabetes. In long-standing T1D, this glucagon response is irreversibly lost [34, 
35]. As a result, the body relies on other counterregulatory responses and takes a 
longer time to normalize the hypoglycemia induced by exercise.  
Hypoglycemia is a potent stimulator of epinephrine. In response to hypoglycemia, 
the adrenal medulla secretes epinephrine which helps to counterregulate low 
glucose levels by promoting glycogenolysis and lipolysis. However, it has been 
found that in T1D patients, the plasma epinephrine levels are one third of their 
healthy counterparts, implying a blunted adrenomedullary response [36]. 
A very crucial factor in glucose recovery from hypoglycemia is the clearance of 
injected insulin. Research indicates that T1D patients have diminished clearance 
of injected insulin as evidenced by the prolonged initial half-time of 
disappearance of injected insulin [36]. It implies that T1D patients develop 
insulin resistance over time, which interferes with glucose uptake and their 
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utilization by the tissues. Another important consideration is the body’s 
dependability on the type of counterregulatory response to hypoglycemia. Studies 
have reported that recovery from insulin-induced hypoglycemia is unaffected by 
adrenergic blockade in healthy controls [37]. It indicates that adrenomedullary 
response (epinephrine secretion) is not critical to glucose recovery from 
hypoglycemia unless glucagon response is absent or reduced [34, 37]. It implies 
that T1D patients, with blunted or absent glucagon response, are dependent on 
epinephrine-mediated response for glucose recovery from hypoglycemia. This 
has been confirmed in studies that showed lower mean blood glucose levels, with 
smaller increments in mean plasma glucagon, in T1D patients when compared to 
their healthy counterparts [38, 39]. 
Exercise-induced hypoglycemia. In healthy people, the insulin levels drop during 
exercise, which stimulates the secretion of glucagon and promotes glycogenolysis. 
In T1D, the exogenous insulin levels do not drop, increasing the risk of exercise-
induced hypoglycemia [39–41].  
There could be several possible reasons for the body’s inability to reduce insulin 
levels. Firstly, the exercise is usually performed in a 0–4-h period following an 
insulin injection. As a result, the insulin levels might not decrease due to the 
inadequate timeframe, and, furthermore, due to the pharmacokinetics of the 
insulin and time of its peak action [15]. Secondly, the injected insulin may get 
absorbed rapidly form the subcutaneous tissue, following exercise, resulting in 
increased insulin levels [42]. The increased levels of insulin promote peripheral 
uptake and utilization of glucose, aggravating the hypoglycemic state, 
complicated by limited glucagon response [43]. Thirdly, T1D patients have an 
attenuated glucagon response to hypoglycemia, decreasing the glycogen 
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breakdown to glucose, which would have countered the hypoglycemia in healthy 
individuals [37, 38, 44].  
In some people with T1D, the glucagon response to exercise may be intact, in 
absence of hypoglycemia [44]. However, the glucagon response may be blunted 
if previously exposed to hypoglycemia [21]. Exercise-induced hypoglycemia may 
also be a result of blunted adrenomedullary responses to exercise in T1D [21]. 
T1D patients with poor glycemic control may have low hepatic glycogen content 
[45], again contributing to exercise-induced hypoglycemia.   
Late glycemic excursions. Many patients with T1D experience exercise-induced 
late-onset hypoglycemia [18], about 7-11 hours post-exercise (“lag effect” of 
exercise) [46, 47]. This might be harmful, especially because unaware: patients 
may unconsciously experience hypoglycemia during sleep. Physical activity 
during the daytime accelerate the risk of nocturnal hypoglycemia to about 30–40% 
[48–52]. This incidence resembles the need to accurately evaluate and identify 
the relative metabolic alterations occurring inside the body. Insulin sensitivity is 
pronounced in T1D immediately after exercise and again 7–11 hours later, 
increasing the risk for late glycemic excursions [46]. This implies the mandatory 
modification in the insulin therapy post exercise, especially the bedtime insulin 
[48]. 
 
3.4 Exercise-induced hyperglycemia 
Decreased insulin levels in the portal circulation can result in hyperglycemia. In 
the absence of insulin, the muscle cells do not utilize glucose as fuel, and instead 
rely on fatty acids and ketones, leading to ketoacidosis. If the glycogenolysis 
from liver continues, without the muscles taking up glucose, the plasma glucose 
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levels can shoot up, resulting in hyperglycemia [53]. Hyperglycemia can ensue 
following high-intensity exercise that increases cathecolamine and cortisol levels 
[54], augmenting, in turn, hepatic glucose production and limiting peripheral 
glucose disposal. In healthy individuals this increase in cathecolamines is 
compensated by for enhanced insulin secretion upon termination of exercise, 
whereas in T1D subjects such a phenomenon might exacerbate post-exercise 
hyperglycemia. However this hyperglycemic effect is transitory in diabetic 
subjects, lasting 1-2 hours in the recovery time [55, 56]. 
Obviously, if a patient has hyperglycemia and presence of urinary ketones, 
exercise should be delayed [57, 58]. Vigorous activity should be avoided 
especially with known insulin omission. Conversely, if elevated blood glucose is 
clearly attributable to underdosing insulin at the preceding meal, exercise may not 
be postponed based solely on hyperglycemia. 
 
3.5 Exercise types  
The physiological response to exercise depends upon the intensity, volume and 
frequency of exercises along with the muscle group involved. The rate of 
glycogen depletion is directly proportional to the intensity of exercise. 
Glycogenolysis is rapid during high-intensity exercise. The process of glycogen 
breakdown is regulated by epinephrine levels. High-intensity exercise increases 
plasma epinephrine levels which in turn increase glycogen breakdown.  
Some exercise types, such as aerobic exercise, even if performed for only 15 min, 
cause a significant increase in plasma GH levels. The peak values are found at the 
end of the activity [59]. Other factors influencing the GH response to exercise 
include physical fitness, gender and age [59]. Studies show a linear dose–
 12 
response between exercise intensity and GH secretion [60, 61]. Research studies 
have also found that sustained endurance training blunts the acute exercise-
induced GH release [62].  
Anaerobic exercise involves intense muscular contraction resulting in 
accumulation of lactic acid. High lactate levels reduce the uptake and utilization 
of plasma glucose and NEFA in the skeletal muscle. It also promotes hepatic 
glucose production. These two mechanisms combined may result in 
hyperglycemia in T1D [63–65]. However, studies show that a 10-s high-intensity 
anaerobic sprint may help prevent early post-exercise hypoglycemia in T1D [66, 
67]. Weight training before the onset of aerobic exercise has also been found to 
be helpful in maintaining the blood glucose levels in T1D [68].  
As previously reported, intense aerobic exercise combined with equally intense 
anaerobic activity may increase blood glucose levels for 1–2 h in recovery [55, 
56]. 
3.5.1 High Intensity Intermittent Training: a possible new frontier of glucose control in 
T1D? 
Intermittent high intensity exercise is a fascinating modality of training that 
consists in moderate intensity exercise with short bouts – repetitive sprinting – of 
interspersed all-out efforts. Few randomized controlled trials have investigated 
the beneficial effects of vigorous intensity exercise, specifically high intensity 
intermittent training, in adults with T1D. As mentioned, a single all-out sprint of 
10 s, upon completion of exercise, may counter the drop in glucose occurring 
post-exercise by activation of GLUT4. Conversely, the same 10 s burst executed 
before exercise did not impede the hypoglycemic event, although a stabilization 
of glycemic levels was achieved post-exercise. In fact, intermittent high-intensity 
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exercise should be preferred over continuous moderate-intensity aerobic exercise 
to help prevent extreme excursion of glucose levels [69, 70]. Furthermore, 
intermittent high-intensity exercise decreases glucose disposal compared with 
continuous moderate intensity exercise, implying a high flexibility of the former 
type of exercise in shifting fuel metabolism towards consumption of alternatives 
substrates [71]. To conclude, intermittent high intensity exercise reduces 
metabolic destabilization post-effort; it offers protection against nocturnal 
hypoglycemia in athletes with T1D [70], and it has been also accompanied with 
enhanced muscle oxidative metabolism in young subjects with T1D [64]. 
International guidelines recommend to have participated at least in regular 
moderate-intensity exercise before performing short bursts of very intense 
activity interspersed with short period of recovery. Evidence for the efficacy of 
this training in obtaining stable glycemic control is lacking, however the optimal 
high-intensity intermittent training protocol has yet to be fully tested and 
determined. 
  
4. How to maximize exercise benefits in T1D 
Over the past decades a wide spectrum of scientific advances have been 
spanned through the diabetes management in order to greatly improve the 
psychological and behavioral burden of these patients. Options offered by technology 
and clinical care are various, ranging from frequent self-monitoring of blood glucose 
(SMBG) to islet-transplantation (IT). Use of blood glucose monitors is pivotal for 
controlling glycemic excursions in response to exercise: insulin and carbohydrate 
intake can be accordingly adjusted to prevent dysglycemic events (hyper-, or more 
often, hypo-glycemic episodes) throughout the day (Figure 3). A couple of glucose 
 14 
measurements prior to exercise, spaced 15-45 min apart, are recommended to identify 
patterns and trends. Ideally, blood glucose checks should be made every 30 min 
during physical activity so that strategies can be operated at the need. Even in the late 
recovery, glucose readings are important because of the increased insulin sensitivity 
occurring 7-11 hours post-exercise [46]. 
Continuous glucose monitoring (CGM) systems use a small sensor, 
inserted under the skin, that provides interstitial glucose readings as often as once per 
minute over a 24 h period. The sensor stays in place for several days up to a week, 
then it must be replaced. The measurements are transmitted to a wireless monitor, 
which allows gathering trends, particularly useful to reconstruct patterns modulated 
by exercise. However, real-time CGM tends to overestimate blood glucose levels in 
the low range, due to the 10-20 min lag time between interstitial fluid and capillary 
glucose. This is notably alarming if hypoglycemia is developing, although short-term 
use of CGM with alarms has been shown to reduce the incidence and duration of 
hypoglycemia to a certain extent [72]. In another study [73], CGM revealed to be 
accurate despite markedly different metabolic and exercise conditions (high-intensity 
intermittent exercise versus continuous moderate). The coupling of CGM with insulin 
pump (continuous subcutaneous insulin infusion, CSII) has been proved to be 
efficient in gaining the beneficial effects of exercise in the management of T1D [6]. 
The CSII is a (relatively recent) technological breakthrough in the T1D therapy, as it 
allows to simulate the physiologic pancreatic secretion of insulin by delivering rapid-
acting insulin analogs throughout the day. With respect to multiple daily insulin 
injections (MDII), CSII offers a larger flexibility and a more accurate insulin 
administration so much as for tiny doses: both bolus insulin and the basal infusion 
rates can be adjusted by the users before, during, and after exercise. CSII is 
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definitively advantageous as the basal insulin reduction following exercise can occur 
automatically during sleep, so to help prevent nocturnal hypoglycemia [48]. 
Furthermore, the introduction of new ultra-long acting basal insulins (insulin degludec, 
insulin glargine U-300) may substantially reduce dosing frequency because of their 
ultralong action profile (lasting >24 h and possibly up to 40 h), resulting in improved 
mental well-being scores [74] and, ultimately, in a drecreased incidence of 
hypoglycemia compared to their rival basal insulin analogs [75]. However, whether 
these new insulins may be efficacious, in relation to the exercise timing, remains to be 
elucidated.  
Although the risks of hypoglycemic events cannot be totally excluded 
even under the strict control operated by CSII plus CGM, this latter combination 
represents one of the most promising automated model toward the pathway to the 
artificial pancreas. 
Apart from closed-loop control systems or artificial pancreas, islet 
transplantation (IT) has become a desirable scenario, whenever possible, on numerous 
scientific and clinical fronts in the therapy and management of T1D [76]. IT restores 
glycemic control awareness and offers protection against severe hypoglycemia, at 
least in the mid-term after trasplant [77]. As to the exercise benefits, β-cells 
transplanted recipients have tremendously improved their medical outcome and 
lifestyle factors (i.e. insulin-independence, above all) even under conditions of ultra-
endurance training [8, 78]. 
With all these technological advances, at the other end of the spectrum, 
there is actually a quite bit of evidence that adequate lifestyle education and training 
to all people with T1D are still poor. Few parallel studies have investigated the rates 
of diabetes education in exercise, and T1D patients have harsh access to certified 
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programs on diabetes self-management training, especially outside of major urban 
areas. Optimal diabetes control will certainly be achieved thanks to breakthrough 
technologies; however, at the simpler level, much more can yet be done on 
dissemination of adequate lifestyle education and adherence to treatment 
recommendations. This is also true when it comes to to exercise benefits in T1D.  
 
5. Aerobic exercise in T1D 
When glycemic control is not deteriorated in individuals with T1D, 
endurance training will likely induce the same adaptions to which healthy subjects 
normally respond to. Therefore aerobic training improves insulin sensitivity, blood 
lipid profile, physical fitness; increases energy expenditure; decreases blood pressure, 
risk of CVD; enhances psychological well-being. These adaptations are still 
appreciable even though glycemic control is not improved. Ultimately, long-term 
health and life expectancy will be favorably impacted by regular aerobic exercise 
even under conditions of impaired glycemic control. For these reasons, in the 
management of T1D, the goal of optimal blood glucose control is of paramount 
relevance. However, a decent glycemic control permits to achieve an elite level of 
sport performance. In a long-distance runner, β-cells transplanted, a high volume of 
aerobic training not only was compatible with the treatment of T1D, but also it 
counteracted diabetic symptoms and mitigated the side effects of immunosuppressive 
drugs and graft dysfunction over a 10-year observation [8, 78]. In a study on 10 
triathletes with T1D, endurance performance was unaffected over 3 years, despite 
typical glycemic dysregulation through the race [79]. A normal cardiopulmonary peak 
was reported in adults with long-standing T1D, in a good glycemic control.  
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T1D adolescents have shown to have an aerobic capacity 20% lower than 
peer-matched healthy controls [80]. A reduced maximal aerobic capacity has been 
reported in young patients with T1D with respect to their non-diabetic peers. Physical 
work capacity seems to be related to the level of glycemic control, which in turn 
explains, to some extent, athletic and sport skill performance. It is still uncertain 
whether reduced work capacity in young subjects with T1D results from poor 
oxygenation [81], low muscular capillarization [82], or if poor metabolic control 
depends on low regular physical activity [83]. 
According to the “American Diabetes Association” position statement [84, 
85], children and adults should perform at least 60 min or more of moderate-to-
vigorous intensity, daily. Adults should be recommended to exercise at least 150 
min/week for 3-7 days per week (with no more than 2 consecutive days of rest) at 
moderate-to-vigorous intensity (50-70% of maximum heart rate; 50-85% of VO2max). 
Adults able to run at about 10 km/h may diminish the aforementioned duration, by 
running 75 min/week (subjectively “vigorously”) on at least 25-min block. 
 
6. Resistance exercise in T1D 
Resistance exercises are based on the use of muscular strength to move a 
weight or work against a resistant load to a maximal extent (strength, force) or 
repeatedly (muscle endurance). Such training not only improves musculoskeletal 
health but it helps to maintain independence in carrying out daily activities, with 
reduced risk of injuries. 
Muscular mass and strength can be positively enhanced by resistance 
training in individuals with T1D. The effects of resistance exercise on glycemic 
control in T1D are still controversial, not univocally ascertained, but promising. For 
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instance, resistance training has been shown to be effective in minimizing risk of 
hypoglycemia post-exercise in T1D [86]. Prior to neuropathic complications, skeletal 
muscle abnormalities have been observed in T1D patients, suggesting the existence of 
a typical diabetic myopathy in humans [83]. Decrements in musculo-skeletal strength, 
loss in muscle fiber size, and increase in glycolytic enzymes and fast-twitch fibers 
have been reported in individuals with T1D. Others have shown slower conduction 
velocity and motor unit discharge frequency during muscular isometric contractions in 
T1D [87]. These factors, along with higher glycolytic flux (e.g. muscle glycogen as 
preferred energy source), early dehydration and acidosis [88], might promote early 
fatigue in these T1D populations (both pediatric- and adult-). 
Hence, appropriately orchestrated resistance training programs may 
counteract this mass remodeling detrimental for the metabolism of T1D subjects. 
Types of resistance training may include weight lifting (free weights), specific 
isotonic machines, bands, isometric exercises and calisthenics. 
 “American Diabetes Association” recommends adults to perform 
moderate (15 repetitions at maximum effort) to vigorous (repetitions at maximum 
effort) resistance activities, 2-3 days/week on non-consecutive days. At least 8-10 
exercises with completion of 1-3 sets of 10-15 repetitions near to fatigue per set [85]. 
Conditioning of the body core and balance training (time standing on a definite 
position) are as well envisaged. Children and youth should incorporate such muscle-
conditioning activities as part of their daily play, games, recreation, physical 
education, family context. Importantly, these activities should exceed the sedentary 
time, by accumulating planned and structured physical effort in the course of daily 
living. 
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Whatever the primary goal of the training will be, either improvements in 
functional capacity or increased ability to care for oneself, the resistance program 
should anyway consider the possible presence of chronic comorbidities typical of the 
disease (neuropathy, vascular damage, CVD). Such health concerns ought to be 
medically addressed before engaging in resistance training. 
 
7. Exercise defense against syndromic inflammation in diabetes 
Several studies documented elevated circulating inflammatory and 
oxidative stress markers in patients with T1D. On a side, oxidative stress may be seen 
as a characteristic trait of T1D, on the other one, hyperglycemia can exacerbate this 
scenario of systemic inflammation. T1D patients exhibit numerous features of 
atherogenesis, including activation of transcription factors stimulating expression of 
proinflammatory cytokines. In reality, a vast array of conditions threatens the 
functionality of the β-pancreatic mass, promoting islet inflammation and metabolic 
stress/imbalance. It is possible that increased stimulation of the β-cells due to 
overfeeding, obesity, insulin resistance, psychological stress, infections, and low 
physical activity, stimulate or sometimes even initiate the autoimmune attack leading 
the insulin-producing islet-cells to the their failure. Exercise triggers a cytokine 
response that may be anti-inflammatory and offers protection to β-cell against all 
these insults.  
Depending on intensity, type and duration, physical exercise is a potent 
modulator of physiological changes at different levels, pertaining stress hormones, 
energy crisis and oxidative stress. Regularly exercising at moderate intensity 
has been shown to enhance the antioxidant defense system, thus reducing the 
oxidative stress. To a variable degree, as already observed in other chronic 
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inflammatory conditions, these exercise-related adaptations may express a favorable 
cytokine pattern and may preserve the β-cell redox homeostasis – and thus its insulin 
secreting capacity – against the multiple-origin attacks directed towards β-cells. 
However, inconclusive data have been reported on exercise-induced cytokine 
response (TNF-α, IL6) with a putative beneficial health effect. According to our 
observations, physical exercise may be helping in two way by both enhancing insulin 
sensitivity (increasing insulin action) and β-cell function through the reduction of the 
deleterious effects of autoimmunity. These two effects are likely to combine together 
and produce a substantial gain in glucose tolerance [4]. 
 
8. Integrative view 
Multiple improvements in health indicators firmly remark that regular 
exercise is essential in the management and lifestyle of people with T1D (Table 2). 
Nevertheless, given the endocrine responses to exercise in T1D are blunted and 
inadequate, clinicians and exercise professionals must allow discretion when 
prescribing physical activity. Exercise programs should be meticulously based on 
close monitoring of physical activity and the body’s response in terms of glycemic 
fluctuations and inflammatory or oxidative parameters. 
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Figure Captions 
 
 
Figure 1. 
Graphical Abstract. The pillars to maximize exercise-benefits in the lifestyle of 
people with type 1 diabetes: properly modulating carbohydrates ingestion before-
during-after exercise, strict monitoring of glucose and insulin, adequacy of healthcare 
professionals, and a comprehensive educational approach. 
 
 
Figure 2. 
Synoptic picture summarizing the metabolic and endocrine responses to moderate, 
constant-load exercise in healthy- and T1D-subjects. 
 
 
Figure 3. 
Scheme of the indications (nutritional and insulin adjustments) for maintaining 
glucose homeostasis during constant-load, moderate exercise in T1D-subjects 
according to the most reported guidelines [85, 89, 90]. 
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Table 1. 
Studies examining the effects of exercise interventions on T1D. 
Authors Subjects Type of exercise  Main outcomes 
    
Andersen et al.[91] Adults with T1D  Isokinetic peak torque of 
dorsal/plantar flexion of ankle 
Torque loss at ankle and 
knee neg. correlates with 
neuropathy 
Andreassen et 
al.[92] 
Adults with T1D Peak torque Torque correlates with 
muscle volume 
Campbell et 
al.[93] 
Male adults on MDI, 
with CGM 
45’ treadmill running Preventing post-exercise 
hypoglycemia with 
↓basal insulin and 
↓prandial bolus insulin 
McAuley et 
al.[94] 
Adults with T1D on 
CSII 
30’ moderate-intensity 
stationary bicycle, 60’ after ↓ 
post-basal 
Exercise-induced 
hypoglycemia was 
prevented only 
with↑insulin basal rate 
supplemental CHO 
Luzi et al.[3] Adults with T1D Regression analysis on 
between autoimmunity 
markers (GAD, IA) and 
weekly energy expenditure 
(EE) derived from physical 
exercise 
↓autoimmunity and 
longer honeymoon in 
↑physycally active 
subjects  
Sherr et al.[95] Adolescents and 
young subjects with 
T1D 
60 min treadmill walking @ 
65-70% HRmax 
↓nocturnal hypoglycemia 
w/ closed-loop insulin 
delivery, regardless of 
activity level in the mid-
afternoon 
Martinez-
Ramonde et 
al.[96] 
Diabetic adults from 
onet to 2-yr period  
Retrospective diary on PA 
programmes adherence 
↑PA allows better 
glycemic control, residual 
pancreatic mass and 
insulin requirements 
Adamo et al.[6] Adults with T1D on 
CSII + CGM 
3 mo observational study on 
PA levels 
↑PA allows better 
metabolic control and 
body composition, 
↓hypoglycemic events  
Davey et al.[97]  Adolescents with 
T1D 
Hyperinsulinemic euglycemic 
clamps during either resting 
or 45 min cycling on an 
ergometer @ ∼ 65% VO2max 
No evidence of biphasic 
pattern of post-exercise 
risk of hypoglycemia 
Tunar et al.[98] Adolescents with 12-wk of Pilates session ↔ HbA1c, ↑peak power, 
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T1D ↑mean power, ↑vertical 
jump and ↑flexibility 
Yardley et al.[99] Adolescents and 
adults with T1D 
RE on aerobically active 
subjects. 3 times/wk; 8RM x 
7 exercise on weight 
machines 
PA recommendations for 
subjects with T1D. 
READI study has not 
been completed yet. 
Bally et al.[71] Young male adults 
with T1D 
High-intensity intermittent 
training versus continuos 
moderate-intensity exercise 
↓Glucose disposal and 
↑flexibilityin high-
intensity intermittent 
training 
Shetty et al.[100] Young adults with 
T1D 
Euglycemic clamps during 
and for 2-hr after different 
intensity exercise (35-80% O2 
peak) 
Inverted U relationship 
between exercise intensity 
and glucose requirement 
Davey et al.[101] Young adults with 
T1D 
Hyperinsulinemic-euglycemic 
clamp during and for 8-hr 
after 30 min of moderate-
intensity exercise on two 
separate occasions followed 
by either a 10-s maximal 
sprint effort or no sprint 
↔ CHO after 10-s sprint 
to maintain euglycemia 
Yardley et al.[68] Young adults with 
T1D 
AE (45 min running @ 60% 
VO2 peak) before RE (3 sets x 
8-7 different exercises) or 
vice versa 
RE before AE improves 
glucose stability dufing 
exercise and ↓ 
hypoglycemia post-
exercise 
Guelfi et al.[69] Young adults with 
T1D 
Euglycemic clamps during  
Moderate-intensity exercise 
(30 min cycling @ 40% 
VO2peak) versus intermittent 
high-intensity exercise (30 
min continuous exercise @ 
40% VO2peak  interspersed 
with additional 4-s maximal 
sprint efforts performed every 
2 min) 
Decline in blood glucose 
in the early recovery is 
less with high-intensity 
intermittent exercise vs 
moderate one 
Iscoe et al.[70] Trained athletes with 
T1D  
Interstitial glucose levels 
measured  during two 
sedentary days and during 2 
days in which 45 min of 
afternoon continuous 
moderate-intensity exercise 
occurred either with or 
without intermittent high-
intensity exercise 
↓Nocturnal hypoglycemia 
with intermittent high-
intensity exercise + 
moderate one 
Harmer et al.[64] Young adults with 
T1D 
Sprint training (cycling @ 
130% VO2 peak) for 7-wk.  
↓metabolic 
destabilization (of lactate, 
H+, 
glycogenolysis/glycolysis, 
and ATP) during intense 
exercise, ↑ Muscle 
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oxidative metabolism 
Komatsu et al.[80, 
102] 
Children, 
adolescents, and 
young adults with 
T1D 
incremental aerobic 
exercising test on a motorized 
treadmill 
Aerobic capacity 20% ↓ 
in T1D vs peer controls 
Veves et al.[103] Young adults with 
T1D 
Observational study between 
physically active and 
sedentary subjects 
Aerobic capacity ↔ in 
physically active people 
with T1D 
Gusso et al.[104] Adolescents with 
T1D, T2D and obese 
Evaluation of maximal 
aerobic capacity on acycle 
ergometer during submaximal 
exercise 
↓Exercise stroke volume 
response and  ↓aerobic 
capacity in diabetic 
adolescents 
Salem et al.[105] Adolescents with 
T1D 
Mixed exercise programs 
(AE+RE) 3 times/wk for 6 
mo 
↓HbA1c, 
↔hypoglycemic 
episodes, BMI improved, 
↓insulin requirements, 
dyslipidemia improved 
Codella et al.[8] An islet-transplanted 
ultra endurance 
runner 
Monitoring of glucose, 
insulin, autoimmunity and 
inflammatory markers before, 
during and after marathon 
periods 
Marathons were 
accompanied by 
marathon’’ period was 
accompanied by ↓HbA1c, 
↓exogenous insulin 
requirement, 
↔autoimmune profile, 
with systemic 
inflammation  
Herbst et al.[106] Children and 
adolescents with 
T1D 
Self-reported regular physical 
activity 
↓total cholesterol, ↓low-
density lipoprotein 
cholesterol, ↓triglyceride 
levels 
Huber et al.[107] Children and 
adolescents with 
T1D 
Two training sessions (lasting 
90-120 min) per d (soccer, 
biking, hiking, swimming,  
ball games) 
↓in mean insulin dosage, 
↓mean HbA1c, ↓total 
ghrelin levels 
Laaksonen et 
al.[108] 
Adults with T1D 30-60 min moderate-intensity 
running 3-5 times/wk for 12-
16 wk. 
Better body composition, 
↔HbA1c, better lipid 
profile 
    
 
Abbreviations: ↑ = significant increase; ↓ = significant decrease; ↔ = no changes; AE = aerobic 
exercise; CHO = carbohydrates; d = day; HR = heart rate; min = minutes; mo = month; PA = physical 
activity; RE = resistance exercise; 1RM = repetition maximum; s = second; T1D = type 1 diabetes; 
VO2 = oxygen uptake; yr = year; wk = week. 
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Table 2. 
Differences between sedentary and active subjects with type 1 diabetes 
 sedentary active 
 
body composition [6, 109] 
 
− 
 
+ 
blood glucose control [6, 8, 110, 111, 96, 
112]  
=/− =/+ 
hypoglycemic episodes [6, 8, 48, 97, 93] =/− − 
hyperglycemic episodes [55, 56, 113] =/− + 
insulin doses [6, 8, 93] − + 
insulin sensitivity [7, 31, 46, 84] − + 
blood lipid profile [111, 112] =/− =/+ 
autoimmunity  [3, 114, 115] − =/+ 
inflammation [96, 115–118] − =/+ 
psychological well-being [112, 119] =/− + 
cardiorespiratory fitness [80, 102, 104] − + 
   
 
=  stable 
+  improvement 
−  deterioration 
 
 
 
 
 39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 
Graphical Abstract. The pillars to maximize exercise-benefits in the lifestyle of 
people with type 1 diabetes: properly modulating carbohydrates ingestion before-
during-after exercise, strict monitoring of glucose and insulin, adequacy of healthcare 
professionals, and a comprehensive educational approach. 
 
 
 
 
 
 40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 
Synoptic picture summarizing the metabolic and endocrine responses to moderate, 
constant-load exercise in healthy- and T1D-subjects. 
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Figure 3. 
Scheme of the indications (nutritional and insulin adjustments) for maintaining 
glucose homeostasis during constant-load, moderate exercise in T1D-subjects 
according to the most reported guidelines [85, 89, 90]. 
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